Healthcare Contract Research Organizations (CRO) Services Market Dynamics and Trends by 2031
Healthcare Contract Research Organizations (CRO) Services Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Indication (Neurological Disorders, Oncology, Respiratory Diseases, Infectious Diseases, Cardiovascular Diseases, and Others); Service Type (Laboratory Services, Early Phase Development, Consulting Services, and Clinical Research Services); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, and Others), and Geography
Historic Data: 2021-2022 | Base Year: 2023 | Forecast Period: 2024-2031- Report Date : Mar 2026
- Report Code : TIPRE00010465
- Category : Life Sciences
- Status : Data Released
- Available Report Formats :

- No. of Pages : 150
The healthcare contract research organizations (CRO) services market size projected to reach US$ 102.86 billion by 2031 from US$ 57.31 billion in 2023. The market is expected to register a CAGR of 7.6% in 2023–2031. The increasing clinical studies globally will likely remain a key healthcare contract research organization's (CRO) services market trend.
Healthcare Contract Research Organizations (CRO) Services Market Analysis
Factors such as increasing demand for novel drugs, increasing chronic diseases prevalence, and growth in funding programs to conduct clinical trials are responsible for propelling the number of clinical trials worldwide. The management of clinical trials requires extended research facilities, dedicated resources, and adequate financial requirements. These prerequisites of clinical trials generate a productive environment to prefer a contract research organization to execute clinical studies. The above factors will boost the market growth over the forecast period.
Healthcare Contract Research Organizations (CRO) Services Market Overview
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms for chronic diseases. Asthma is the most common chronic disease among children across the globe and the WHO estimated that around 263 million people are living with asthma across the globe. Thus, the growing prevalence of chronic disorders is likely to lead to the development of new pharmaceuticals, which will further accelerate the growth of the healthcare contract research organizations (CRO) services market.
Customizee This Report To Suit Your Requirement
Get FREE CUSTOMIZATIONHealthcare Contract Research Organizations (CRO) Services Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Healthcare Contract Research Organizations (CRO) Services Market Drivers and Opportunities
Increasing Outsourcing Activities to Favor Market
Many companies are establishing strategic partnerships with contract research organizations. For instance, in January 2020, Aragen Bioscience, Inc, a subsidiary of GVK BIO, one of the significant players in pre-clinical CRO, entered into a strategic collaboration with Serum Institute of India Pvt. Ltd. to accelerate the R&D of multiple stable cell lines under Serum’s HIV program. Moreover, In 2022, Labcorp spin off its CRO segment, named Fortrea, which stands to “forward trials with ease” will work as an independent publicly traded CRO, and provide drug and medical device services, including clinical trial management and commercialization offerings.
Rising Biosimilars and Biologics Market – An Opportunity in Healthcare Contract Research Organizations (CRO) Services Market
The biotechnology industry expands scientists' toolboxes, and the combination of basic research, translational studies, and clinical trials will continue to develop, investigate, and test additional compounds, techniques, and therapeutic pathways. Biotechnology is a strategic sector for China. The Made in China 2025 initiative aims to produce high-tech products, including innovative medicines. The plan introduced targets for Chinese pharmaceutical companies to spur biotechnology innovation and increase exports. Furthermore, these Asian countries use genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing evolution of the biotechnology industry in developing regions will create opportunities for the biologics and biosimilars market in the coming years.
Healthcare Contract Research Organizations (CRO) Services Market Report Segmentation Analysis
Key segments contributing to the derivation of the Healthcare Contract Research Organizations (CRO) Services market analysis are service type, therapeutic indication, and end user.
- Based on service type, the healthcare contract research organizations (CRO) services market is divided into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held a larger market share in 2023.
- Based on therapeutic indication, the market is segmented into oncology, infectious diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others. The others segment held a larger market share in 2023.
- In terms of end user, the market is segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.
Healthcare Contract Research Organizations (CRO) Services Market Share Analysis by Geography
The geographic scope of the Healthcare Contract Research Organizations (CRO) Services market report is mainly divided into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The healthcare contract research organizations (CRO) services market in North America is significant. In North America, the growth of the healthcare contract research organizations (CRO) services market is primarily driven by high regulatory standards followed by the pharmaceutical industry, an increasing number of clinical trials, and the rapid growth of the biosimilars and biologics market. Marge pharmaceutical companies are expected to grow R&D spending at 4% per annum, I.e., US$234 billion by 2025. Likewise, biotechnology R&D spending is forecast to grow up to 8% per annum. The above factors is expected to affect the healthcare contract research organizations (CRO) positively services market growth.
Healthcare Contract Research Organizations (CRO) Services Market Regional InsightsThe regional trends and factors influencing the Healthcare Contract Research Organizations (CRO) Services Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Healthcare Contract Research Organizations (CRO) Services Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Healthcare Contract Research Organizations (CRO) Services Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 57.31 Billion |
| Market Size by 2031 | US$ 102.86 Billion |
| Global CAGR (2023 - 2031) | 7.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Service Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Healthcare Contract Research Organizations (CRO) Services Market Players Density: Understanding Its Impact on Business Dynamics
The Healthcare Contract Research Organizations (CRO) Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
- Get the Healthcare Contract Research Organizations (CRO) Services Market top key players overview
Healthcare Contract Research Organizations (CRO) Services Market News and Recent Developments
The Healthcare Contract Research Organizations (CRO) Services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
- In June 2021, LINK Medical, a full-service contract research organization (CRO) for the pharmaceutical and medical device industries, signed a contract to join forces with Insife, an expert consulting and technology service provider for safety and pharmacovigilance organizations. (Source: LINK Medical, Press Release)
- In April 2020, Accelerated Enrollment Solutions (AES), a business of PPD, Inc., launched a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites from other research facilities that the coronavirus crisis has impacted. (Source: PPD, Inc, Newsletter)
Healthcare Contract Research Organizations (CRO) Services Market Report Coverage and Deliverables
The “Healthcare Contract Research Organizations (CRO) Services Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:
- Healthcare Contract Research Organizations (CRO) Services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Healthcare Contract Research Organizations (CRO) Services market trends
- Detailed PEST and SWOT analysis
- Healthcare Contract Research Organizations (CRO) Services market covering key market trends, Global and regional framework, major players, regulations, and recent market developments
- Healthcare Contract Research Organizations (CRO) Services industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For